Two draft manuscripts look at long term protections offered by this vaccine.
Omicron cases less likely to require hospital treatment, studies show
High rate of infectiousness could still strain hospitals around the world.
FDA gives emergency authorization to Pfizer’s COVID-19 pill
COVID-19 patients as young as 12 are eligible for enzyme-inhibiting treatment.
Biden’s omicron battle plan includes 500 million home test kits
President Biden outlined the federal government’s response to omicron’s ascendancy.
Current vaccines are enough to fight omicron, but massive wave is coming fast
With just 17% of the US boosted, a massive omicron wave could peak in January.
Hospital beds full, National Guard deployed amid crushing delta wave
Pennsylvania hospitals are running at 110%, while Maine and New York call National Guard.
Omicron weakens vaccine protection, but boosters revive defenses, early data finds
Omicron is “a tractable problem with the tools we have.”
Omicron found in US—plus 23 other countries in 5 of 6 global regions
If we can’t defeat delta, we don’t stand a chance against omicron, WHO warns.
Why Omicron quickly became a variant of concern
The WHO lets Omicron skip over variant of interest, go straight to concern.
To help people with long COVID, scientists need to define it
Patients with the perplexing syndrome have reported 200 different symptoms.